ConductScience.org, home

Paper18924115

Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.

Schreck S and 6 others. Hematol Oncol, 2009. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Papers, record 18924115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18924115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.
PubMed
Journal
Hematol Oncol
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
2.66
iCite
Revised in PubMed
2025-01-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schreck SSabine
2Friebel DDaniela
3Buettner MMaike
4Distel LLuitpold
5Grabenbauer GGerhard
6Young LSLawrence S
7Niedobitek GGerald

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hodgkin DiseaseMajor topic
Lymphocytes, Tumor-InfiltratingMajor topic
T-Lymphocytes, RegulatoryMajor topic
Th1 CellsMajor topic
Animals
Antibody Specificity
Disease-Free Survival
Forkhead Transcription Factors
Humans
Immunohistochemistry
Prognosis
Proto-Oncogene Proteins c-maf
Survivors
T-Box Domain Proteins
T-bet Transcription Factor

Source PubMed

Download CSV of topics

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
42074324The Hodgkin Lymphoma Microenvironment: Insights from Spatial Transcriptomics.Int J Mol Sci2026https://conductscience.org/library/papers/42074324PubMed
41813615A Link Between Allergy and Hematological Malignancies? Focus on Possible Mechanisms and the Potential Role of Biological Therapies.Clin Transl Allergy2026https://conductscience.org/library/papers/41813615PubMed
40941026Hodgkin Lymphoma Classification-From Historical Concepts to Current Refinements.Cancers (Basel)2025https://conductscience.org/library/papers/40941026PubMed
39642846Tumor-Infiltrating Immune Cells in Colorectal Cancer.Neoplasia2025https://conductscience.org/library/papers/39642846PubMed
39465401Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?Cancer Cell Int2024https://conductscience.org/library/papers/39465401PubMed
38680717Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?Int J Hematol Oncol Stem Cell Res2024https://conductscience.org/library/papers/38680717PubMed
38672668Th2 Cells Are Associated with Tumor Recurrence Following Radiation.Cancers (Basel)2024https://conductscience.org/library/papers/38672668PubMed
38398216Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma.Cancers (Basel)2024https://conductscience.org/library/papers/38398216PubMed
38328613Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus.Cancer Pathog Ther2023https://conductscience.org/library/papers/38328613PubMed
38148013Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma.J Clin Exp Hematop2023https://conductscience.org/library/papers/38148013PubMed
37452117The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer.Br J Cancer2023https://conductscience.org/library/papers/37452117PubMed
37372147Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications.Biology (Basel)2023https://conductscience.org/library/papers/37372147PubMed
36980536Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy.Cancers (Basel)2023https://conductscience.org/library/papers/36980536PubMed
36900230A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.Cancers (Basel)2023https://conductscience.org/library/papers/36900230PubMed
36405691Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.Front Immunol2022https://conductscience.org/library/papers/36405691PubMed
36325271Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment.Hemasphere2022https://conductscience.org/library/papers/36325271PubMed
36311750Immune-infiltrating signature-based classification reveals CD103+CD39+ T cells associate with colorectal cancer prognosis and response to immunotherapy.Front Immunol2022https://conductscience.org/library/papers/36311750PubMed
36230815Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma.Cancers (Basel)2022https://conductscience.org/library/papers/36230815PubMed
35267668The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good.Cancers (Basel)2022https://conductscience.org/library/papers/35267668PubMed
35095898Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.Front Immunol2021https://conductscience.org/library/papers/35095898PubMed

See all 74 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18924115

GET https://conductscience.org/api/papers/v1/18924115/cited_by?page=2